Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy

• Váldodahkkit: Yu Kondo (Dahkki), Tomoya Tachi (Dahkki), Takayoshi Sakakibara (Dahkki), Jun Kato (Dahkki), Takahito Mizuno (Dahkki), Yoshio Miyake (Dahkki), Hitomi Teramachi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Olanzapine has been shown to have an additive effect on the three-drug antiemetic therapy consisting of aprepitant, palonosetron, and dexamethasone, in a highly emetogenic cisplatin-containing chemotherapy. Although olanzapine may be more economical than aprepitant or palonosetro...